These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32939012)

  • 1. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.
    Yuan J; Song Y; Pan W; Li Y; Xu Y; Xie M; Shen Y; Zhang N; Liu J; Hua H; Wang B; An C; Yang M
    Oncogene; 2020 Oct; 39(43):6664-6676. PubMed ID: 32939012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRE11-RAD50-NBS1 Complex Is Sufficient to Promote Transcription by RNA Polymerase II at Double-Strand Breaks by Melting DNA Ends.
    Sharma S; Anand R; Zhang X; Francia S; Michelini F; Galbiati A; Williams H; Ronato DA; Masson JY; Rothenberg E; Cejka P; d'Adda di Fagagna F
    Cell Rep; 2021 Jan; 34(1):108565. PubMed ID: 33406426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CARD8-AS1 suppresses lung adenocarcinoma progression by enhancing TRIM25-mediated ubiquitination of TXNRD1.
    Pan C; Wang Q; Wang H; Deng X; Chen L; Li Z
    Carcinogenesis; 2024 May; 45(5):311-323. PubMed ID: 38153696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
    Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
    J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
    Chen Y; Gao H; Li Y
    Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs associated with lymph node metastasis in thyroid cancer based on TCGA database.
    Liu R; Liu W; Xue J; Jiang B; Wei Y; Yin Y; Li P
    Pathol Res Pract; 2024 Apr; 256():155255. PubMed ID: 38492360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor.
    Li H; Yan R; Chen W; Ding X; Liu J; Chen G; Zhao Q; Tang Y; Lv S; Liu S; Yu Y
    FEBS J; 2021 Jan; 288(1):212-228. PubMed ID: 32255252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
    Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
    J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.
    Huang Y; Zhang K; Li Y; Dai Y; Zhao H
    Aging (Albany NY); 2020 Nov; 12(22):23326-23336. PubMed ID: 33197895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
    Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
    J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer.
    Dai W; Tian Y; Jiang B; Chen W
    Biomed Pharmacother; 2018 Mar; 99():191-197. PubMed ID: 29331858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.